Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Enhanced Transduction Lentivector Gene Therapy for Treatment of Older Patients with X-Linked Severe Combined Immunodeficiency

Blood (2019) 134 (Supplement_1): 608.

https://doi.org/10.1182/blood-2019-127439

Published: 2019

Journal Articles

Robust Cell Selections and Depletions across Various Hematopoietic Cell Fractions on the Clinimacs Plus Instrument

Thejaswi Bikkani, MBBS, Katherine Li, Anusha Rao, Angela Pickett, Xiaobai Li, PhD, Minoo Battiwalla, MD, Richard W. Childs, MD, John Barrett, MD, Andre Larochelle, MD PhD, Elizabeth Kang, MD, David F. Stroncek, Sandhya R. Panch, MD MPH

Blood (2018) 132 (Supplement 1): 3818.

https://doi.org/10.1182/blood-2018-99-118582

Published: 2018

Journal Articles

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Sarah Bryant, BS, Ian Moore, PhD, Bianca Nagata, Danielle Springer, VMD, DACLAM, Audrey Noguchi, Morteza Peiravi, Karlie Sharma, PhD, Sherry M. Koontz, Harry Malech, MD, Elizabeth Kang, MD

Blood (2017) 130 (Supplement 1): 3172.

https://doi.org/10.1182/blood.V130.Suppl_1.3172.3172

Published: 2017

Journal Articles

Long-Term Vector Integration Site Analysis Following Retroviral Mediated Gene Transfer to Hematopoietic Stem Cells for the Treatment of HIV Infection.

Jun Hayakawa, MD, PhD, Matthew Hsieh, MD, Naoya Uchida, MD, Kareem Washington, PhD, Oswald Phang, Elizabeth Kang, MD, John F. Tisdale, MD

Blood (2008) 112 (11): 2350.

https://doi.org/10.1182/blood.V112.11.2350.2350

Published: 2008

Journal Articles

Multiple Integration Events into Several Putative Oncogenes Was Required To Cause Leukemogenesis in Two Primate Recipients of RCR Contaminated Stem-Cells.

Martin A. Pule, MD, Alexandra Rousseau, MD, Elizabeth Kang, MD, Takahiro Ueda, MD, Christof von Kalle, Arthur W. Nienhuis, MD, Helen Heslop, MD, Elio Vanin, PhD, John F. Tisdale, MD

Blood (2004) 104 (11): 2102.

https://doi.org/10.1182/blood.V104.11.2102.2102

Published: 2004

NARROW

Enhanced Transduction Lentivector Gene Therapy for Treatment of Older Patients with X-Linked Severe Combined Immunodeficiency

Robust Cell Selections and Depletions across Various Hematopoietic Cell Fractions on the Clinimacs Plus Instrument

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Long-Term Vector Integration Site Analysis Following Retroviral Mediated Gene Transfer to Hematopoietic Stem Cells for the Treatment of HIV Infection.

Multiple Integration Events into Several Putative Oncogenes Was Required To Cause Leukemogenesis in Two Primate Recipients of RCR Contaminated Stem-Cells.

Email alerts

ASH Publications

American Society of Hematology

Enhanced Transduction Lentivector Gene Therapy for Treatment of Older Patients with X-Linked Severe Combined Immunodeficiency

Robust Cell Selections and Depletions across Various Hematopoietic Cell Fractions on the Clinimacs Plus Instrument

Allogenic C57B/6->B6D2F1 Transplantation As a Model for Graft Versus Host Disease in the Brain

Long-Term Vector Integration Site Analysis Following Retroviral Mediated Gene Transfer to Hematopoietic Stem Cells for the Treatment of HIV Infection.

Multiple Integration Events into Several Putative Oncogenes Was Required To Cause Leukemogenesis in Two Primate Recipients of RCR Contaminated Stem-Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only